Compare Enveric Biosciences Inc (ENVB) vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF (SJNK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF — how do they compare? Enveric Biosciences Inc trades at $1.41 (market cap $5.32M), while State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF trades at $24.94. The key difference: State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | SJNK | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Sector/Thematic |
52-Week High | $17.40 | $25.63 |
52-Week Low | $1.28 | $24.75 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
SJNK trades at $24.945, up 0.14% on the day, with a bearish technical signal from moving averages and neutral oscillators. The ETF maintains consistent monthly dividend distributions, including recent payments of $0.14 and $0.15 per share. Recent news highlights institutional accumulation by Berkshire Money Management but cautions on high-yield bond exposure amid economic uncertainty.
Outlook remains cautious due to bearish technical indicators and analyst skepticism about high-yield bond sustainability. Risks include interest rate sensitivity and credit spread volatility, while the dividend yield offers income appeal. Investors should weigh income stability against potential capital depreciation in a tightening cycle.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF
SJNK invests in U.S. dollar-denominated high-yield corporate bonds with short-term maturities (under five years). It offers higher yields than investment-grade funds but with less interest rate sensitivity than longer-term junk bond ETFs.
Read more on SJNK →
